Immunocore Holdings plc (IMCR) Operating income 2021–2025
Immunocore Holdings plc (IMCR) annual operating income history from SEC filings — each fiscal year as reported.
-$45.4MFY2025 · since FY2021: -$174.6M → -$45.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$45.4M | +35.6% |
| FY2024 | -$70.5M | -18.1% |
| FY2023 | -$59.6M | -15.4% |
| FY2022 | -$51.7M | +70.4% |
| FY2021 | -$174.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More IMCR financial trends
IMCR RevenueIMCR Net incomeIMCR Net marginIMCR Gross profitIMCR Gross marginIMCR Operating marginIMCR Operating cash flowIMCR Free cash flowIMCR Capital expendituresIMCR Return on equityIMCR Stock buybacksIMCR Dividends paidIMCR Total assetsIMCR Total liabilitiesIMCR Shareholders’ equityIMCR overview →